Mild renal impairment and cardiovascular outcomes in type 2 diabetes: results from the FIELD study

被引：0
|
作者：
Drury, P. L. [1 ]
机构：
[1] NHMRC, Clin Trials Ctr, FIELD Study Invest, Sydney, NSW, Australia
来源：
DIABETOLOGIA | 2006年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0007
引用
收藏
页码：6 / 7
页数：2
相关论文
共 50 条
  • [1] Linagliptin in patients with type 2 diabetes and cardiovascular and/or renal disease: results from a cardiovascular and renal outcomes trial
    Guthrie, Robert
    POSTGRADUATE MEDICINE, 2020, 132 (04) : 314 - 319
  • [2] Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
    Gerstein, Hertzel C.
    Sattar, Naveed
    Rosenstock, Julio
    Ramasundarahettige, Chinthanie
    Pratley, Richard
    Lopes, Renato D.
    Lam, Carolyn S. P.
    Khurmi, Nardev S.
    Heenan, Laura
    Del Prato, Stefano
    Dyal, Leanne
    Branch, Kelley
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (10): : 896 - 907
  • [3] Association of renal status and cardiovascular risk, and safety of fenofibrate in renal impairment in the FIELD study of 9,795 subjects with type 2 diabetes
    Ting, R.
    Davis, T. M. E.
    Jenkins, A. J.
    Drury, P. L.
    Donoghoe, M. W.
    Rajamani, J. K.
    Kesaniemi, A. Y.
    Best, J. D.
    Keech, A. C.
    DIABETOLOGIA, 2011, 54 : S24 - S24
  • [4] Effects of mild to moderate renal impairment on albiglutide (ALBI) in type 2 diabetes
    Bainbridge, V.
    Ahren, B.
    Jones-Leone, A.
    Acusta, A.
    Leiter, L. A.
    DIABETOLOGIA, 2016, 59 : S359 - S359
  • [5] Renal Outcomes in Type 2 Diabetes: A Review of Cardiovascular and Renal Outcome Trials
    Williams, David M.
    Nawaz, Asif
    Evans, Marc
    DIABETES THERAPY, 2020, 11 (02) : 369 - 386
  • [6] Renal Outcomes in Type 2 Diabetes: A Review of Cardiovascular and Renal Outcome Trials
    David M. Williams
    Asif Nawaz
    Marc Evans
    Diabetes Therapy, 2020, 11 : 369 - 386
  • [7] Type 2 Diabetes and Mild Cognitive Impairment
    Qu Mei-Hua
    Fang Chun-Yan
    Zhang Xiu-Rong
    Zhao Chun-Zhen
    Mao Shu-Mei
    Gao Zhi-Qin
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2012, 39 (08) : 791 - 795
  • [8] Liraglutide and renal outcomes in Type 2 diabetes: results of the 'Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results' (LEADER) trial
    Poulter, N.
    Mann, J. F. E.
    Brown-Frandsen, K.
    Daniels, G. H.
    Kristensen, P.
    Nauck, M. A.
    Nissen, S. E.
    Pocock, S.
    Buse, J. B.
    Petrie, J.
    DIABETIC MEDICINE, 2017, 34 : 23 - 24
  • [9] Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment: The Action to Control Cardiovascular Risk in Diabetes Study
    Papademetriou, Vasilios
    Lovato, Laura
    Tsioufis, Costas
    Cushman, William
    Applegate, William B.
    Mottle, Amy
    Punthakee, Zubin
    Nylen, Eric
    Doumas, Michael
    AMERICAN JOURNAL OF NEPHROLOGY, 2017, 45 (02) : 136 - 145
  • [10] Advances in type 2 diabetes therapy: a focus on cardiovascular and renal outcomes
    Libianto, Renata
    Davis, Timothy M. E.
    Ekinci, Elif I.
    MEDICAL JOURNAL OF AUSTRALIA, 2020, 212 (03) : 133 - 139
12345